![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | RGD:732607 | 6480464 | ethylene dichloride results in decreased expression of STMN2 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:732607 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of STMN2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:732607 | 6480464 | Ethinyl Estradiol results in increased expression of STMN2 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of STMN2 mRNA | CTD | PMID:29097150 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:732607 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STMN2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | RGD:69000 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of STMN2 mRNA | CTD | PMID:17404688 | 17beta-estradiol 3-benzoate | increases expression | EXP | | 6480464 | estradiol 3-benzoate results in increased expression of STMN2 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:732607 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STMN2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of STMN2 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69000 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of STMN2 mRNA | CTD | PMID:21998131 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | RGD:69000 | 6480464 | 2 more ... | CTD | PMID:26705709 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of STMN2 mRNA | CTD | PMID:30071829 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69000 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STMN2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:69000 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STMN2 mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:732607 | 6480464 | Fenretinide results in increased expression of STMN2 mRNA | CTD | PMID:28973697 | 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:69000 | 6480464 | Decitabine affects the expression of STMN2 mRNA | CTD | PMID:23300844 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of STMN2 mRNA | CTD | PMID:24780913 | aflatoxin B1 | decreases methylation | ISO | RGD:69000 | 6480464 | Aflatoxin B1 results in decreased methylation of STMN2 gene | CTD | PMID:27153756 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of STMN2 mRNA | CTD | PMID:16483693 | arotinoid acid | multiple interactions | ISO | RGD:69000 | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 | arsane | decreases expression | ISO | RGD:732607 | 6480464 | Arsenic results in decreased expression of STMN2 mRNA | CTD | PMID:19654921 | arsenic atom | decreases expression | ISO | RGD:732607 | 6480464 | Arsenic results in decreased expression of STMN2 mRNA | CTD | PMID:19654921 | arsenite(3-) | increases methylation | ISO | RGD:69000 | 6480464 | arsenite results in increased methylation of STMN2 promoter | CTD | PMID:23974009 | belinostat | increases expression | ISO | RGD:69000 | 6480464 | belinostat results in increased expression of STMN2 mRNA | CTD | PMID:26272509 | belinostat | multiple interactions | ISO | RGD:69000 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STMN2 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of STMN2 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | decreases methylation | ISO | RGD:69000 | 6480464 | Benzo(a)pyrene results in decreased methylation of STMN2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | RGD:732607 | 6480464 | Benzo(a)pyrene results in decreased expression of STMN2 mRNA | CTD | PMID:23735875 | benzo[a]pyrene | increases expression | ISO | RGD:69000 | 6480464 | Benzo(a)pyrene results in increased expression of STMN2 mRNA | CTD | PMID:22316170 | benzo[b]fluoranthene | increases expression | ISO | RGD:732607 | 6480464 | benzo(b)fluoranthene results in increased expression of STMN2 mRNA | CTD | PMID:26377693 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:69000 | 6480464 | Diethylhexyl Phthalate results in increased expression of STMN2 mRNA | CTD | PMID:31163220 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | bisphenol A | decreases expression | ISO | RGD:732607 | 6480464 | bisphenol A results in decreased expression of STMN2 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of STMN2 mRNA | CTD | PMID:30816183 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of STMN2 mRNA | CTD | PMID:25181051 | Brodifacoum | decreases expression | EXP | | 6480464 | bromfenacoum results in decreased expression of STMN2 protein | CTD | PMID:28903499 | Butylparaben | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of STMN2 mRNA | CTD | PMID:19167457 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of STMN2 mRNA | CTD | PMID:33453195 | carbon nanotube | decreases expression | ISO | RGD:732607 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CHIR 99021 | multiple interactions | ISO | RGD:69000 | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 | ciguatoxin CTX1B | affects expression | ISO | RGD:732607 | 6480464 | Ciguatoxins affects the expression of STMN2 mRNA | CTD | PMID:18353800 | cisplatin | affects expression | ISO | RGD:69000 | 6480464 | Cisplatin affects the expression of STMN2 mRNA | CTD | PMID:23300844 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of STMN2 mRNA | CTD | PMID:18375950 | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of STMN2 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of STMN2 mRNA | CTD | PMID:26033743 | cortisol | multiple interactions | ISO | RGD:69000 | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 | crocidolite asbestos | decreases expression | ISO | RGD:732607 | 6480464 | Asbestos, Crocidolite results in decreased expression of STMN2 mRNA | CTD | PMID:29279043 | DDE | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | dexamethasone | multiple interactions | ISO | RGD:69000 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STMN2 mRNA | CTD | PMID:28628672 | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | doramapimod | increases expression | EXP | | 6480464 | doramapimod results in increased expression of STMN2 mRNA | CTD | PMID:24303162 | dorsomorphin | multiple interactions | ISO | RGD:69000 | 6480464 | [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | enzacamene | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | epoxiconazole | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | ethanol | increases expression | ISO | RGD:732607 | 6480464 | Ethanol results in increased expression of STMN2 mRNA | CTD | PMID:30319688 | ethanol | affects splicing | ISO | RGD:732607 | 6480464 | Ethanol affects the splicing of STMN2 mRNA | CTD | PMID:30319688 | etoposide | decreases expression | ISO | RGD:732607 | 6480464 | Etoposide results in decreased expression of STMN2 mRNA | CTD | PMID:25270620 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of STMN2 mRNA | CTD | PMID:27387713 | indometacin | multiple interactions | ISO | RGD:69000 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STMN2 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:69000 | 6480464 | Ivermectin results in decreased expression of STMN2 protein | CTD | PMID:32959892 | L-ascorbic acid | multiple interactions | ISO | RGD:69000 | 6480464 | [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mRNA | CTD | PMID:34480604 | L-ascorbic acid 2-phosphate | multiple interactions | ISO | RGD:69000 | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mRNA | CTD | PMID:34480604 | linuron | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | methylazoxymethanol | increases expression | ISO | RGD:732607 | 6480464 | methylazoxymethanol results in increased expression of STMN2 mRNA | CTD | PMID:17107856 | methylmercury chloride | increases expression | ISO | RGD:69000 | 6480464 | methylmercuric chloride results in increased expression of STMN2 mRNA | CTD | PMID:23179753 more ... | methylmercury chloride | multiple interactions | ISO | RGD:69000 | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STMN2 mRNA | CTD | PMID:27188386 | mifepristone | increases expression | ISO | RGD:69000 | 6480464 | Mifepristone results in increased expression of STMN2 mRNA | CTD | PMID:17584828 | N-methyl-N-nitrosourea | decreases expression | ISO | RGD:732607 | 6480464 | Methylnitrosourea results in decreased expression of STMN2 mRNA | CTD | PMID:25270620 | nickel atom | decreases expression | ISO | RGD:69000 | 6480464 | Nickel results in decreased expression of STMN2 mRNA | CTD | PMID:25583101 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of STMN2 mRNA | CTD | PMID:33484710 | ozone | multiple interactions | ISO | RGD:732607 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of STMN2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of STMN2 mRNA | CTD | PMID:34911549 | panobinostat | multiple interactions | ISO | RGD:69000 | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STMN2 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | RGD:69000 | 6480464 | panobinostat results in increased expression of STMN2 mRNA | CTD | PMID:26272509 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of STMN2 mRNA | CTD | PMID:32680482 | pirinixic acid | multiple interactions | ISO | RGD:69000 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STMN2 mRNA | CTD | PMID:19710929 | prochloraz | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | procymidone | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | progesterone | multiple interactions | ISO | RGD:69000 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of STMN2 mRNA | CTD | PMID:17404688 | rotenone | increases expression | ISO | RGD:69000 | 6480464 | Rotenone results in increased expression of STMN2 mRNA | CTD | PMID:33512557 | sarin | decreases expression | ISO | RGD:69000 | 6480464 | Sarin results in decreased expression of STMN2 mRNA | CTD | PMID:19522546 | SB 431542 | multiple interactions | ISO | RGD:69000 | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386, PMID:34480604 | thalidomide | decreases expression | ISO | RGD:732607 | 6480464 | Thalidomide results in decreased expression of STMN2 mRNA | CTD | PMID:26217789 | titanium dioxide | decreases expression | ISO | RGD:732607 | 6480464 | titanium dioxide results in decreased expression of STMN2 mRNA | CTD | PMID:23409001, PMID:27760801 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of STMN2 mRNA | CTD | PMID:33387578 | trichostatin A | increases expression | ISO | RGD:69000 | 6480464 | trichostatin A results in increased expression of STMN2 mRNA | CTD | PMID:24935251 more ... | trichostatin A | multiple interactions | ISO | RGD:69000 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STMN2 mRNA | CTD | PMID:27188386 | triclosan | increases expression | ISO | RGD:69000 | 6480464 | Triclosan results in increased expression of STMN2 mRNA | CTD | PMID:30510588 | uranium atom | affects expression | ISO | RGD:69000 | 6480464 | Uranium affects the expression of STMN2 mRNA | CTD | PMID:15672453 | valproic acid | increases expression | ISO | RGD:732607 | 6480464 | Valproic Acid results in increased expression of STMN2 mRNA | CTD | PMID:19136453, PMID:20546886 | valproic acid | multiple interactions | ISO | RGD:69000 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STMN2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | RGD:69000 | 6480464 | Valproic Acid results in increased expression of STMN2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | RGD:732607 | 6480464 | Valproic Acid affects the expression of STMN2 mRNA | CTD | PMID:26072468 | valproic acid | affects expression | ISO | RGD:69000 | 6480464 | Valproic Acid affects the expression of STMN2 mRNA | CTD | PMID:25979313, PMID:26072468 | vinclozolin | multiple interactions | EXP | | 6480464 | [Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of STMN2 mRNA | CTD | PMID:25607892 | vorinostat | increases expression | ISO | RGD:69000 | 6480464 | vorinostat results in increased expression of STMN2 mRNA | CTD | PMID:26272509 | vorinostat | multiple interactions | ISO | RGD:69000 | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STMN2 mRNA | CTD | PMID:27188386 | XAV939 | multiple interactions | ISO | RGD:69000 | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of STMN2 mRNA | CTD | PMID:34480604 | |